Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""CEPHALOSPORINS"" wg kryterium: Temat


Starter badań:

Tytuł :
Novel Cephalosporin Conjugates Display Potent and Selective Inhibition of Imipenemase-Type Metallo-β-Lactamases.
Autorzy :
Tehrani KHME; Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Wade N; Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Mashayekhi V; Division of Cell Biology, Department of Biology, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH Utrecht, The Netherlands.
Brüchle NC; Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Jespers W; Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, SE-751 24 Uppsala, Sweden.; Division of Drug Discovery & Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
Voskuil K; Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Pesce D; Laboratory of Genetics, Wageningen University and Research, 6700 AA Wageningen, The Netherlands.; Department of Evolutionary Biology and Environmental Studies, University of Zurich, Winterthurerstrasse 190, 8057 Zurich, Switzerland.
van Haren MJ; Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.
van Westen GJP; Division of Drug Discovery & Safety, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands.
Martin NI; Biological Chemistry Group, Institute of Biology Leiden, Leiden University, Sylviusweg 72, 2333 BE Leiden, The Netherlands.
Pokaż więcej
Źródło :
Journal of medicinal chemistry [J Med Chem] 2021 Jul 08; Vol. 64 (13), pp. 9141-9151. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Bacterial Agents/*pharmacology
Cephalosporins/*pharmacology
beta-Lactamase Inhibitors/*pharmacology
beta-Lactamases/*metabolism
Anti-Bacterial Agents/chemical synthesis ; Anti-Bacterial Agents/chemistry ; Cephalosporins/chemical synthesis ; Cephalosporins/chemistry ; Dose-Response Relationship, Drug ; Molecular Structure ; Structure-Activity Relationship ; beta-Lactamase Inhibitors/chemical synthesis ; beta-Lactamase Inhibitors/chemistry
Czasopismo naukowe
Tytuł :
Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogens.
Autorzy :
Jorda A; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Zeitlinger M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2021 Jul; Vol. 14 (7), pp. 777-791. Date of Electronic Publication: 2021 Apr 26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anti-Bacterial Agents/*pharmacology
Cephalosporins/*pharmacology
Gram-Negative Bacteria/*drug effects
Animals ; Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/pharmacokinetics ; Cephalosporins/adverse effects ; Cephalosporins/pharmacokinetics ; Drug Resistance, Bacterial ; Gram-Negative Bacteria/isolation & purification ; Gram-Negative Bacterial Infections/drug therapy ; Gram-Negative Bacterial Infections/microbiology ; Humans
Czasopismo naukowe
Tytuł :
Transmission of extended-spectrum cephalosporin-resistant Salmonella harboring a bla CMY-2 -carrying IncA/C 2 plasmid chromosomally integrated by ISEcp1 or IS26 in layer breeding chains in Japan.
Autorzy :
Shigemura H; Division of Pathology and Microbiology, Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, 39 Mukaizano, Dazaifu, Fukuoka 818-0135, Japan.
Maeda T; MP AGRO Co., Ltd., 2-44-3 Hoshikuma, Jonan-ku, Fukuoka 814-0132, Japan.
Nakayama S; Division of Pathology and Microbiology, Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, 39 Mukaizano, Dazaifu, Fukuoka 818-0135, Japan.
Ohishi A; Division of Pathology and Microbiology, Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, 39 Mukaizano, Dazaifu, Fukuoka 818-0135, Japan.
Carle Y; Division of Pathology and Microbiology, Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, 39 Mukaizano, Dazaifu, Fukuoka 818-0135, Japan.
Ookuma E; Division of Pathology and Microbiology, Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, 39 Mukaizano, Dazaifu, Fukuoka 818-0135, Japan.
Etoh Y; Division of Pathology and Microbiology, Department of Health Science, Fukuoka Institute of Health and Environmental Sciences, 39 Mukaizano, Dazaifu, Fukuoka 818-0135, Japan.
Hirai S; Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan.
Matsui M; Antimicrobial Resistance Research Center, National Institute of Infectious Diseases, 4-2-1 Aoba-cho, Higashi-Murayama, Tokyo 189-0002, Japan.
Kimura H; Department of Health Science, Gunma Paz University Graduate School of Health Sciences, Takasaki, Gunma 370-0006, Japan.
Sekizuka T; Pathogen Genomics Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Kuroda M; Pathogen Genomics Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan.
Sera N; Department of Occupational Therapy, Teikyo University Fukuoka Campus, 6-22 Misaki-machi, Omuta, Fukuoka 836-8505, Japan.
Inoshima Y; Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences, Gifu University, 1-1 Yanagido, Gifu, Gifu 501-1193, Japan.
Murakami K; Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan.
Pokaż więcej
Źródło :
The Journal of veterinary medical science [J Vet Med Sci] 2021 Sep 03; Vol. 83 (9), pp. 1345-1355. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Cephalosporins*/pharmacology
Salmonella enterica*/genetics
Animals ; Anti-Bacterial Agents/pharmacology ; Chickens ; Drug Resistance, Multiple, Bacterial/genetics ; Female ; Japan ; Plasmids/genetics ; Salmonella/genetics ; beta-Lactamases/genetics
Czasopismo naukowe
Tytuł :
Development of a Broad-Specific Competitive ELISA for First-Generation Cephalosporin Antibiotics in Animal-Derived Foods Samples.
Autorzy :
Liu M; College of Food Science and Technology, Hebei Agricultural University, Baoding, 071001, China.
Sang Y; College of Food Science and Technology, Hebei Agricultural University, Baoding, 071001, China.
Zhang J; College of Food Science and Technology, Hebei Agricultural University, Baoding, 071001, China.
Li J; College of Food Science and Technology, Hebei Agricultural University, Baoding, 071001, China.
Yu W; College of Food Science and Technology, Hebei Agricultural University, Baoding, 071001, China.
Zhang F; College of Food Science and Technology, Hebei Agricultural University, Baoding, 071001, China.
Wang X; College of Food Science and Technology, Hebei Agricultural University, Baoding, 071001, China. .
Pokaż więcej
Źródło :
Bulletin of environmental contamination and toxicology [Bull Environ Contam Toxicol] 2021 Aug; Vol. 107 (2), pp. 215-220. Date of Electronic Publication: 2020 May 29.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Bacterial Agents*
Cephalosporins*
Animal Feed ; Animals ; Chromatography, High Pressure Liquid ; Enzyme-Linked Immunosorbent Assay ; Rabbits
Czasopismo naukowe
Tytuł :
Consumption of cephalosporins in the community, European Union/European Economic Area, 1997-2017.
Autorzy :
Versporten A; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Bruyndonckx R; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Hasselt University, Data Science Institute, Hasselt, Belgium.
Adriaenssens N; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Hens N; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Hasselt University, Data Science Institute, Hasselt, Belgium.; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Monnet DL; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Molenberghs G; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Hasselt University, Data Science Institute, Hasselt, Belgium.; Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), Catholic University of Leuven, Leuven, Belgium.
Goossens H; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Weist K; Disease Programmes Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Coenen S; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.; Centre for General Practice, Department of Family Medicine & Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.
Pokaż więcej
Corporate Authors :
ESAC-Net study group
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 26; Vol. 76 (12 Suppl 2), pp. ii22-ii29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Bacterial Infections*/drug therapy
Cephalosporins*
Anti-Bacterial Agents/therapeutic use ; Drug Utilization ; European Union ; Humans ; Outpatients
Czasopismo naukowe
Tytuł :
Microbiological Characterization of VNRX-5236, a Broad-Spectrum β-Lactamase Inhibitor for Rescue of the Orally Bioavailable Cephalosporin Ceftibuten as a Carbapenem-Sparing Agent against Strains of Enterobacterales Expressing Extended-Spectrum β-Lactamases and Serine Carbapenemases.
Autorzy :
Chatwin CL; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Hamrick JC; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Trout REL; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Myers CL; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Cusick SM; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Weiss WJ; UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Pulse ME; UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas, USA.
Xerri L; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Burns CJ; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Moeck G; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Daigle DM; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
John K; MTF Biologics, Edison, New Jersey, USA.
Uehara T; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Pevear DC; Venatorx Pharmaceuticals, Incorporated, Malvern, Pennsylvania, USA.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Jul 16; Vol. 65 (8), pp. e0055221. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Cephalosporins*/pharmacology
beta-Lactamase Inhibitors*/pharmacology
Animals ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Bacterial Proteins ; Carbapenems/pharmacology ; Ceftibuten ; Mice ; Microbial Sensitivity Tests ; Serine ; beta-Lactamases/genetics
Czasopismo naukowe
Tytuł :
Sigmoid E max Modeling To Define the Fixed Concentration of Enmetazobactam for MIC Testing in Combination with Cefepime.
Autorzy :
Knechtle P; Allecra Therapeutics SAS, Saint-Louis, France.
Shapiro S; Allecra Therapeutics SAS, Saint-Louis, France.
Morrissey I; IHMA Europe Sàrl, Monthey, Switzerland.
De Piano C; IHMA Europe Sàrl, Monthey, Switzerland.
Belley A; Allecra Therapeutics SAS, Saint-Louis, France.
Pokaż więcej
Źródło :
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Jul 16; Vol. 65 (8), pp. e0092621. Date of Electronic Publication: 2021 Jul 16.
Typ publikacji :
Journal Article
MeSH Terms :
Cephalosporins*/pharmacology
beta-Lactamases*/genetics
Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Azabicyclo Compounds/pharmacology ; Cefepime ; Humans ; Klebsiella pneumoniae ; Microbial Sensitivity Tests ; Triazoles
Czasopismo naukowe
Tytuł :
The feasibility of implementing antibiotic restrictions for fluoroquinolones and cephalosporins: a mixed-methods study across 15 Veterans Health Administration hospitals.
Autorzy :
Livorsi DJ; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Suda KJ; Center for Health Equity Research and Promotion (CHERP), VA Pittsburgh Health Care System, Pittsburgh, PA, USA.; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Cunningham Goedken C; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA.
Hockett Sherlock S; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Balkenende E; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Chasco EE; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Scherer AM; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Goto M; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Perencevich EN; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Goetz MB; VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.; David Geffen School of Medicine at the University of California in Los Angeles, CA, USA.
Reisinger HS; Center for Access & Delivery Research and Evaluation (CADRE), Iowa City Veterans Affairs Health Care System, Iowa City, IA, USA.; Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Pokaż więcej
Corporate Authors :
Veterans Affairs-Centers for Disease Control and Prevention Practice-Based Research Network
Źródło :
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Jul 15; Vol. 76 (8), pp. 2195-2203.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Cephalosporins*
Fluoroquinolones*
Anti-Bacterial Agents/therapeutic use ; Feasibility Studies ; Hospitals ; Humans ; Veterans Health
Czasopismo naukowe
Tytuł :
Cephalosporin antibiotics specifically and selectively target nasopharyngeal carcinoma through HMOX1-induced ferroptosis.
Autorzy :
He X; School of Public Health, Kunming Medical University, Kunming, Yunnan, China. Electronic address: .
Yao Q; Institute of Yunnan Cancer, the Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Fan D; School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Duan L; School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
You Y; School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Liang W; School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Zhou Z; School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Teng S; School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Liang Z; School of Public Health, Kunming Medical University, Kunming, Yunnan, China.
Hall DD; Department of Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA.
Song LS; Department of Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA.
Chen B; Department of Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Jul 15; Vol. 277, pp. 119457. Date of Electronic Publication: 2021 Apr 05.
Typ publikacji :
Journal Article
MeSH Terms :
Cephalosporins/*pharmacology
Ferroptosis/*physiology
Nasopharyngeal Carcinoma/*metabolism
Animals ; Apoptosis/drug effects ; Cell Cycle/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Cephalosporins/metabolism ; China ; Ferroptosis/genetics ; Heme Oxygenase-1/metabolism ; Heme Oxygenase-1/physiology ; Humans ; MAP Kinase Signaling System/drug effects ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Nasopharyngeal Carcinoma/drug therapy ; Signal Transduction/drug effects ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
A new approach to recycling cephalosporin fermentation residue into plant biostimulants.
Autorzy :
Cai C; State Key Laboratory of Pollution Control and Resources Reuse, College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China.
Hua Y; State Key Laboratory of Pollution Control and Resources Reuse, College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China.
Liu H; State Key Laboratory of Pollution Control and Resources Reuse, College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China.
Dai X; State Key Laboratory of Pollution Control and Resources Reuse, College of Environmental Science and Engineering, Tongji University, Shanghai 200092, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of hazardous materials [J Hazard Mater] 2021 Jul 05; Vol. 413, pp. 125393. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cephalosporins*
Biomass ; Fermentation ; Hydrolysis ; Temperature
Czasopismo naukowe
Tytuł :
Cefdinir-Associated "Bloody Stools": No Need to Scope.
Autorzy :
Panchoo AV; Department of Pediatrics, Baylor, College of Medicine, Houston, TX; Division of Gastroenterology, Hepatology and Nutrition, The Children's Hospital of San Antonio, San Antonio, TX .
Noel JM
Pokaż więcej
Źródło :
Pediatric emergency care [Pediatr Emerg Care] 2021 Jul 01; Vol. 37 (7), pp. e421.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Bacterial Agents*/adverse effects
Cephalosporins*/adverse effects
Cefdinir ; Gastrointestinal Hemorrhage ; Humans
Czasopismo naukowe
Tytuł :
PHARMACOKINETICS AND CLINICAL SAFETY OF A SUSTAINED-RELEASE FORMULATION OF CEFTIOFUR CRYSTALLINE FREE ACID IN RINGNECK DOVES ( STREPTOPELIA RISORIA ) AFTER A SINGLE INTRAMUSCULAR INJECTION.
Autorzy :
Valitutto MT; Wildlife Conservation Society, Zoological Health Program, Bronx, NY 10460, USA, .
Newton AL; Wildlife Conservation Society, Zoological Health Program, Bronx, NY 10460, USA.
Wetzlich S; Department of Medicine and Epidemiology, University of California, Davis, CA 95616, USA.
Kishbaugh JC; Heartland Niagara Animal Hospital, 7885 McLeod Road, Niagara Falls, Ontario L2H 2Y6, Canada.
Raphael BL; Wildlife Conservation Society, Zoological Health Program, Bronx, NY 10460, USA.
Calle PP; Wildlife Conservation Society, Zoological Health Program, Bronx, NY 10460, USA.
Tell LA; Department of Medicine and Epidemiology, University of California, Davis, CA 95616, USA.
Pokaż więcej
Źródło :
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians [J Zoo Wildl Med] 2021 Apr; Vol. 52 (1), pp. 81-89.
Typ publikacji :
Clinical Trial, Veterinary; Journal Article
MeSH Terms :
Anti-Bacterial Agents/*pharmacokinetics
Cephalosporins/*pharmacokinetics
Columbidae/*metabolism
Animals ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/blood ; Area Under Curve ; Cephalosporins/administration & dosage ; Cephalosporins/blood ; Columbidae/blood ; Delayed-Action Preparations ; Half-Life ; Injections, Intramuscular
Czasopismo naukowe
Tytuł :
US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®).
Autorzy :
Naseer S; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Weinstein EA; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Rubin DB; Division of Biometrics IV, Office of Biostatistics, Center for Drug Evaluation and Research, US FDA, Silver Spring, Maryland, USA.
Suvarna K; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Wei X; Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US FDA, Silver Spring, Maryland, USA.
Higgins K; Division of Biometrics IV, Office of Biostatistics, Center for Drug Evaluation and Research, US FDA, Silver Spring, Maryland, USA.
Goodwin A; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Jang SH; Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US FDA, Silver Spring, Maryland, USA.
Iarikov D; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Farley J; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Nambiar S; Division of Anti-Infectives, Office of Infectious Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration (FDA), Silver Spring, Maryland, USA.
Pokaż więcej
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Jun 15; Vol. 72 (12), pp. e1103-e1111.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Anti-Bacterial Agents*/therapeutic use
Cephalosporins*
Adult ; Gram-Negative Bacteria ; Humans ; United States ; United States Food and Drug Administration
Czasopismo naukowe
Tytuł :
Using precision dosing to minimize cefepime-induced neurotoxicity: The challenge of targets.
Autorzy :
Al-Shaer MH; Infectious Disease Pharmacokinetics Lab, College of Pharmacy and Emerging Pathogens Institute, University of Florida, 1600 SW Archer Rd, PO Box 100486, Gainesville, FL 32610, USA. Electronic address: .
Peloquin CA; Infectious Disease Pharmacokinetics Lab, College of Pharmacy and Emerging Pathogens Institute, University of Florida, 1600 SW Archer Rd, PO Box 100486, Gainesville, FL 32610, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2021 Jun; Vol. 27 (6), pp. 929-930. Date of Electronic Publication: 2021 Mar 02.
Typ publikacji :
Letter
MeSH Terms :
Anti-Bacterial Agents*/adverse effects
Cephalosporins*/adverse effects
Cefepime ; Humans
Opinia redakcyjna
Tytuł :
Real-life experience with ceftolozane/tazobactam in Canada: results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry.
Autorzy :
Zhanel GG; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Electronic address: .
Dhami R; Department of Pharmacy, London Health Sciences Centre, London, Ontario, Canada.
Baxter M; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Kosar J; Department of Pharmacy, Royal University Hospital, Saskatoon, Saskatchewan, Canada.
Cervera C; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Irfan N; Department of Pharmacy, Hamilton Health Sciences Centre, Hamilton, Ontario, Canada.
Zvonar R; Department of Pharmacy, Ottawa Hospital, Ottawa, Ontario, Canada.
Borgia S; Section of Infectious Diseases, William Osler Health System, Brampton, Ontario, Canada.
Tessier JF; Pharmacy Department, CIUSSS de l'Est-de-l'Île-de-Montréal, Montreal, Québec, Canada.
Dow G; Section of Infectious Diseases, Department of Medicine, The Moncton Hospital, New Brunswick, Canada.
Ariano R; Department of Pharmacy, St Boniface Hospital, Winnipeg, Manitoba, Canada.
Dube M; Department of Pharmacy, Sainte-Croix Hospital, Drummondville, Québec, Canada.
Savoie M; Pharmacy Department, CIUSSS de l'Est-de-l'Île-de-Montréal, Montreal, Québec, Canada.
Bassetti M; Infectious Diseases Clinic, Department of Health Sciences, University of Genoa and Policlinico San Marino IRCCS, Genoa, Italy.
Walkty A; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Karlowsky JA; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Pokaż więcej
Źródło :
Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2021 Jun; Vol. 25, pp. 346-350. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cephalosporins*/therapeutic use
Leadership*
Anti-Bacterial Agents/therapeutic use ; Canada ; Humans ; Registries ; Tazobactam
Czasopismo naukowe
Tytuł :
Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens.
Autorzy :
Choby JE; Emory Antibiotic Resistance Center and Emory Vaccine Center, Atlanta, GA 30329, USA.
Ozturk T; Emory Antibiotic Resistance Center and Emory Vaccine Center, Atlanta, GA 30329, USA.
Satola SW; Emory Antibiotic Resistance Center and Emory Vaccine Center, Atlanta, GA 30329, USA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA, USA.
Jacob JT; Emory Antibiotic Resistance Center and Emory Vaccine Center, Atlanta, GA 30329, USA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, GA, USA.
Weiss DS; Emory Antibiotic Resistance Center and Emory Vaccine Center, Atlanta, GA 30329, USA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. Electronic address: .
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 May; Vol. 21 (5), pp. 597-598.
Typ publikacji :
Letter; Comment
MeSH Terms :
Carbapenems*/pharmacology
Cephalosporins*
Gram-Negative Bacteria ; Humans
Opinia redakcyjna
Tytuł :
Immediate Reactions to Cephalosporins: It is Time to Standardize the Diagnostic Essence.
Autorzy :
Sabato V; Department of Immunology, Allergology, Rheumatology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.
Poorten MV; Department of Immunology, Allergology, Rheumatology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium; Department of Paediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium.
Ebo DG; Department of Immunology, Allergology, Rheumatology, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp University Hospital, Antwerp, Belgium. Electronic address: .
Pokaż więcej
Źródło :
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Apr; Vol. 9 (4), pp. 1658-1659.
Typ publikacji :
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms :
Cephalosporins*
Penicillins*
Humans ; Skin Tests
Raport
Tytuł :
Different classes of antibiotics given to women routinely for preventing infection at caesarean section.
Autorzy :
Williams MJ; Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
Carvalho Ribeiro do Valle C; Infection Prevention and Control, Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM, Department of Obstetrics and Gynaecology, University of Campinas, Campinas, Brazil.
Gyte GM; Cochrane Pregnancy and Childbirth Group, Department of Women's and Children's Health, University of Liverpool, Liverpool, UK.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 Mar 04; Vol. 3. Cochrane AN: CD008726. Date of Electronic Publication: 2021 Mar 04.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Anti-Bacterial Agents/*therapeutic use
Bacterial Infections/*prevention & control
Cephalosporins/*therapeutic use
Cesarean Section/*adverse effects
Penicillins/*therapeutic use
Postoperative Complications/*prevention & control
Anti-Bacterial Agents/adverse effects ; Anti-Bacterial Agents/classification ; Antibiotic Prophylaxis/methods ; Cephalosporins/adverse effects ; Female ; Humans ; Infant, Newborn ; Penicillins/adverse effects ; Pregnancy ; Puerperal Infection/prevention & control ; Randomized Controlled Trials as Topic ; beta-Lactamase Inhibitors/therapeutic use
Czasopismo naukowe
Tytuł :
Clinical outcomes of ceftobiprole in the treatment of acute bacterial skin and skin structure infections.
Autorzy :
Lee GM; Department of Nursing, Kaohsiung Municipal United Hospital, Taiwan.
Chao CM; Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan, Taiwan.
Lai CC; Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of global antimicrobial resistance [J Glob Antimicrob Resist] 2021 Mar; Vol. 24, pp. 303-305. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :
Letter; Comment
MeSH Terms :
Cephalosporins*/therapeutic use
Gram-Positive Bacteria*
Opinia redakcyjna
Tytuł :
A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment.
Autorzy :
Kumar R; Department of Biotechnology and Bioinformatics, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh, 173 234, India. Electronic address: .
Kumar V; Division of Life Science, Department of Bio & Medical Big Data (BK21 Four Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju, 52828, Republic of Korea.
Lee KW; Division of Life Science, Department of Bio & Medical Big Data (BK21 Four Program), Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Research Institute of Natural Science (RINS), Gyeongsang National University (GNU), 501 Jinju-daero, Jinju, 52828, Republic of Korea. Electronic address: .
Pokaż więcej
Źródło :
Computers in biology and medicine [Comput Biol Med] 2021 Mar; Vol. 130, pp. 104186. Date of Electronic Publication: 2020 Dec 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Coronavirus 3C Proteases*/antagonists & inhibitors
Coronavirus 3C Proteases*/chemistry
Drug Repositioning*
Molecular Dynamics Simulation*
SARS-CoV-2*/chemistry
SARS-CoV-2*/enzymology
COVID-19/*drug therapy
COVID-19/*enzymology
Cephalosporins/*chemistry
Hepacivirus/*enzymology
Hepatitis C/*drug therapy
Oligopeptides/*chemistry
Cephalosporins/therapeutic use ; Hepatitis C/enzymology ; Humans ; Oligopeptides/therapeutic use
SCR Protocol :
COVID-19 drug treatment
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies